Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda ...

Plus Therapeutics has partnered with SpectronRx for the production of Rhenium (186Re) obisbemeda, a targeted radiotherapy for ...

Plus Therapeutics (PSTV) and SpectronRx announced the signing of a Manufacturing Services Agreement, MSA, for the production of Rhenium ...

On Monday, BWX Technologies announced a signed purchase agreement to acquire L3Harris Technologies' Aerojet Ordnance ...

德克萨斯州奥斯汀 - 临床阶段制药公司Plus Therapeutics, Inc. (NASDAQ:PSTV)与放射性药物合同开发和制造商SpectronRx合作,生产用于中枢神经系统 (CNS)癌症的先进放射疗法。今天宣布的制造服务协议 (MSA)聚焦于Rhenium (186Re) Obisbemeda,该疗法旨在治疗CNS癌症,包括脑膜转移和复发性胶质母细胞瘤。

Nuclear fusion could be an ideal solution to mankind's energy problem, guaranteeing a virtually limitless source of power ...

Northern Dynasty Minerals (NYSEAMERICAN:NAK – Free Report) (TSE:NDM) had its price objective raised by HC Wainwright from $0.80 to $1.30 in a report issued on Wednesday morning,Benzinga reports. HC ...

BWX Technologies (BWXT) and L3Harris (LHX) announced the signing of a purchase agreement for BWXT to acquire L3Harris’ Aerojet Ordnance ...

Can theory and computation methods help the search for the best divertor material and thus contribute to making fusion energy ...

BWX Technologies has agreed to acquire L3Harris Technologies ’ Aerojet Ordnance Tennessee business for $100 million.

Using rhenium–osmium and uranium–lead dating, the research reveals that biogenic graphite was hydrothermally remobilized in shear zones during late orogenesis, indicating periodic carbon ...